A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
Checked against the public recordLast updated Dec 27, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Screening
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Georgetown University
- Interventions being studied
- Behavioral: Provider Prompt & Patient Outreach and Education
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * 50-80 years old; * current cigarette smoker or quit within 15 years; * a 20+ pack-year smoking history; * non-adherent to lung screening (\>13 months); * English-speaking; * scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and * able and willing to provide meaningful consent and complete telephone interviews Exclusion Criteria: * Individuals with a history of lung cancer
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- MedStar HealthWashington D.C., District of Columbia
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 27, 2024. Always confirm current availability with the study team.